The Quiet Comeback of Periactin – Why an Old Allergy Pill Keeps Showing Up in New Places

Periactin has an almost unyielding quality. The small white tablet has outlived most of its counterparts in the antihistamine market. It is sold in foil strips that haven’t really changed in design in decades. It is still available when you walk into a pharmacy in Karachi, London, or São Paulo. It is usually located behind the counter, is frequently dusty, and is frequently less expensive than the more recent medications that are arranged around it. In a market that typically rewards novelty, it is an odd survivor.

The medication has been working for more than 60 years, in one form or another, since it was patented in 1959. It was originally used as a treatment for hay fever. The typical suspects include sneezing, itching, and watery eyes. However, doctors started observing other things at some point. Patients put on weight. The migraines subsided. Some slept deeper. It turned out that the medication was doing more than just inhibiting histamine. It was influencing acetylcholine, dopamine, and serotonin in ways that no one had fully anticipated.

The story becomes convoluted at that point. In the medical field, cyproheptadine—a generic name that practically nobody outside of a pharmacy can pronounce on their first try—became a kind of Swiss Army knife. It was first prescribed by pediatricians to children who were malnourished, especially those with cystic fibrosis or cancer treatments. According to a 2008 study, it could safely encourage children with treatment-related cachexia—the clinical term for the body wasting away—to gain weight. That has a subtle kind of utility, the kind of thing that doesn’t make headlines but is very important to families.

Then there are those who suffer from migraines. According to a 2013 study, attacks decreased dramatically from almost nine episodes per month to roughly three within seven to ten days of beginning Periactin. These kinds of numbers are simple to recite but difficult to feel, but for someone who suffers from migraines, the difference can mean the difference between being able to function and not. Although researchers are still unsure of the precise mechanism, it’s possible that the drug’s serotonin-blocking action contributes to its effectiveness.

However, there are some disadvantages to periactin. The sedation is genuine. After the first few doses, some patients report experiencing dry mouth, dizziness, and a strange foggy feeling. The medical community has moved away from first-generation medications for common allergies in part because newer antihistamines, such as loratadine, cause fewer of these problems. Nevertheless, periactin continues to occupy new areas of medicine. Off-label uses include serotonin syndrome, cyclic vomiting in infants, akathisia in antipsychotic patients, and even persistent insomnia.

Considering how frequently the medication is discreetly prescribed, it is difficult to ignore how infrequently it is discussed in public. With more than a million prescriptions written in 2023, it was the 234th most prescribed drug in the US. That footprint is quite large. However, the majority of people would not recognize the name if asked.

As this develops, there’s a feeling that Periactin symbolizes something more significant about the real workings of medicine. Because they are affordable, accessible, and beneficial, drugs continue to be used, sometimes unintentionally and sometimes after decades of off-label experimentation. It’s still unclear if something newer will eventually take the place of Periactin. The old tablet continues to function quietly for the time being.